Literature DB >> 32075812

Intravenous immunoglobulins in an adult case of post-EBV cerebellitis.

Eleonora D'Ambrosio1, Farnaz Khalighinejad2, Carolina Ionete3.   

Abstract

Post-Epstein-Barr virus (EBV) cerebellitis is very rare complication of infectious mononucleosis and only a few adult cases are reported in literature. We present a 23-year-old patient who was admitted to the neurology service with worsening ataxia, nystagmus and dysarthria, 1 week after infectious mononucleosis. Imaging and cerebrospinal fluid studies were normal, serum studies revealed acute transaminitis and positive EBV viral capsid IgM and IgG. The patient underwent a 5-day course of intravenous immunoglobulins with rapid resolution of all his symptoms and was safely discharged home. The pathophysiology of post-EBV cerebellitis involves autoreactive antibodies, rather than a direct viral insult. Antineuronal antibodies might be the result of a mimicry between EBV proteins and neuronal antigens or they can be secreted by the EBV-transformed lymphocytes themselves. Many reports stress the benign, self-limiting nature of this syndrome; however, immunotherapy might de facto decrease the severity and duration of illness. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Brain stem/cerebellum; infection (neurology); neurology

Mesh:

Substances:

Year:  2020        PMID: 32075812      PMCID: PMC7046430          DOI: 10.1136/bcr-2019-231661

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

1.  Intravenous immunoglobulin therapy for acute cerebellar ataxia.

Authors:  T Go
Journal:  Acta Paediatr       Date:  2003-04       Impact factor: 2.299

Review 2.  Epstein-Barr virus.

Authors:  Hal B Jenson
Journal:  Pediatr Rev       Date:  2011-09

3.  Autoantibodies in postinfectious acute cerebellar ataxia.

Authors:  Ayumi Uchibori; Manabu Sakuta; Susumu Kusunoki; Atsuro Chiba
Journal:  Neurology       Date:  2005-10-11       Impact factor: 9.910

4.  Brain perfusion in acute encephalitis: relationship to prognosis studied using SPECT.

Authors:  T Nara; H Nozaki; H Nishimoto
Journal:  Pediatr Neurol       Date:  1990 Nov-Dec       Impact factor: 3.372

5.  Cerebellar ataxia and glutamic acid decarboxylase antibodies: immunologic profile and long-term effect of immunotherapy.

Authors:  Helena Ariño; Nuria Gresa-Arribas; Yolanda Blanco; Eugenia Martínez-Hernández; Lidia Sabater; Mar Petit-Pedrol; Idoia Rouco; Luis Bataller; Josep O Dalmau; Albert Saiz; Francesc Graus
Journal:  JAMA Neurol       Date:  2014-08       Impact factor: 18.302

6.  Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia.

Authors:  Kazunori Nanri; Mitsunori Okita; Masafumi Takeguchi; Takeshi Taguchi; Tomoko Ishiko; Hirohiko Saito; Takao Otsuka; Hiroshi Mitoma; Kiyoshi Koizumi
Journal:  Intern Med       Date:  2009-05-15       Impact factor: 1.271

7.  Detection of acute Epstein Barr virus cerebellitis using sequential brain HMPAO-SPECT imaging.

Authors:  Jeong Wook Park; Young Bin Choi; Kwang Soo Lee
Journal:  Clin Neurol Neurosurg       Date:  2004-03       Impact factor: 1.876

Review 8.  Acute cerebellitis.

Authors:  Yukio Sawaishi; Goro Takada
Journal:  Cerebellum       Date:  2002-07       Impact factor: 3.847

9.  Cerebellar encephalitis in adults.

Authors:  T Klockgether; G Döller; U Wüllner; D Petersen; J Dichgans
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

10.  An Adult Case of Acute EBV Cerebellitis.

Authors:  Katya Muscat; Ruth Galea; Malcolm Vella
Journal:  Eur J Case Rep Intern Med       Date:  2017-01-27
View more
  3 in total

1.  Case Report: Epstein-Barr Virus Encephalitis Complicated With Brain Stem Hemorrhage in an Immune-Competent Adult.

Authors:  Lingtong Huang; Xuan Zhang; Xueling Fang
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 2.  Epstein-Barr Virus and Neurological Diseases.

Authors:  Nan Zhang; Yuxin Zuo; Liping Jiang; Yu Peng; Xu Huang; Lielian Zuo
Journal:  Front Mol Biosci       Date:  2022-01-10

Review 3.  A Breakdown of Immune Tolerance in the Cerebellum.

Authors:  Christiane S Hampe; Hiroshi Mitoma
Journal:  Brain Sci       Date:  2022-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.